Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Medley (4480 JP)
Watchlist
44
Analysis
Health Care
•
Japan
Medley, Inc. operates medical webs. The Company provides medical human resource recruitment, medical system management, online medical treatment, medical information updating, and other services. Medley provides its services throughout Japan.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Medley
•
07 Oct 2024 23:36
Medley (4480 JP): Strong Base Business; No Fear from Fx; Digital Healthcare Push to Benefit
Although Medley has reported mixed 2Q24 result, with robust topline and declining profitability, the long-term growth potential remains intact. The...
Tina Banerjee
Follow
463 Views
Share
bullish
•
JSR Corp
•
02 Apr 2024 07:00
(Mostly) Asia M&A, Mar 2024: Chilled & Frozen, TDCX, MMA Offshore, JSR, Roland DG, SciClone
For the month of March, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$4bn. The average premium for the new deals...
David Blennerhassett
Follow
656 Views
Share
bullish
•
JSR Corp
•
09 Mar 2024 20:00
(Mostly) Asia-Pac M&A: Genex, Alumina, Azure Minerals, Vinda, JSR Corp, Shinko Electric Industries
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
605 Views
Share
bullish
•
JSR Corp
•
04 Mar 2024 00:32
Merger Arb Mondays (04 Mar) - JSR, Shinko, Outsourcing, APM, Alumina, Adbri, Azure, CSR, Probiotec
This week, the highest gross spreads are APM (19.8%), Probiotec (10.2%), Alumina (10.1%), Shinko Electric (7.9%), JSR (7.4%), China TCM (5.7%),...
Arun George
Follow
444 Views
Share
bullish
•
Medley
•
29 Feb 2024 09:30
Medley (4480 JP): 2023 Result Beats Guidance; Sees Flat Profit on Double-Digit Sales Growth in 2024
Medley reports strong 2023 result with sales, EBITDA, and net profit rising 45%, 77%, and 152%, YoY, respectively. Company sets ambitious mid-term...
Tina Banerjee
Follow
354 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x